Coloplast has seen its share price fall a long way over the past few years, yet recent gains have nudged the stock higher ...

SEB raised its target for Coloplast stock from DKK 500.00 to DKK 515.00 on October 19, 2026, according to MarketScreener.

Major shareholder announcement Reference is made to the press release issued by Coloplast A/S on 4 September 2026 regarding the expected implementation of the generational change in the ultimate ...

Coloplast is a leading global supplier of intimate healthcare products with a strong product portfolio and high market share. The company has a stable business model and benefits from demographic ...

Coloplast stock faces JPMorgan's DKK 377.00 target after a September 9 downgrade. The 9M report showed 6% organic growth and a 26% EBIT margin.

Coloplast is now a clear Buy, trading nearly 60% below its all-time high and at historically low valuation multiples. CLPBF's wide economic moat, underpinned by patents and high switching costs, ...

Add Yahoo as a preferred source to see more of our stories on Google. Aug 18 (Reuters) - Medical equipment maker Coloplast expects its Kerecis wound-care business to return to growth from January 2027 ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Coloplast interim CEO Lars Rasmussen has today informed the Coloplast Board of Directors that he will not stand for re-election as board member at the upcoming annual general meeting on December 4, ...

Though foreign-exchange headwinds have nagged at Coloplast COLO B, underlying demand remains robust and revenue growth remains on track to meet our full-year projections. We’re holding steady on our ...

Aug 18 (Reuters) - Medical equipment maker Coloplast (COLOb.CO), opens new tab expects its Kerecis wound-care business to return to growth from January 2027 after changes to U.S. Medicare payments ...